0001493152-22-017153.txt : 20220617
0001493152-22-017153.hdr.sgml : 20220617
20220617160544
ACCESSION NUMBER: 0001493152-22-017153
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220616
FILED AS OF DATE: 20220617
DATE AS OF CHANGE: 20220617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cohen Cheryl
CENTRAL INDEX KEY: 0001529371
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15006
FILM NUMBER: 221023771
MAIL ADDRESS:
STREET 1: C/O MEDIVATION, INC.
STREET 2: 201 SPEAR ST., 3RD FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celldex Therapeutics, Inc.
CENTRAL INDEX KEY: 0000744218
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 133191702
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 53 FRONTAGE ROAD
STREET 2: SUITE 220
CITY: HAMPTON
STATE: NJ
ZIP: 08827
BUSINESS PHONE: 908-200-7500
MAIL ADDRESS:
STREET 1: 53 FRONTAGE ROAD
STREET 2: SUITE 220
CITY: HAMPTON
STATE: NJ
ZIP: 08827
FORMER COMPANY:
FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19980828
FORMER COMPANY:
FORMER CONFORMED NAME: T CELL SCIENCES INC
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0306
4
2022-06-16
0
0000744218
Celldex Therapeutics, Inc.
CLDX
0001529371
Cohen Cheryl
C/O CELLDEX THERAPEUTICS, INC.
53 FRONTAGE ROAD, SUITE 220
HAMPTON
NJ
08827
1
0
0
0
Non-Qualified Stock Option (right to buy)
22.48
2022-06-16
4
A
0
27200
0.00
A
2032-06-16
Common Stock
27200
27200
D
Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.
One third vests on the first, second and third anniversaries of the date of grant.
/s/ Sam Martin, attorney-in-fact for Cheryl L. Cohen
2022-06-17